Latin American Cannabis Co. Blueberries Medical Wraps Up 2023 With Multi-Million Dollar Private Placement Deal
Latin American Cannabis Co. Blueberries Medical Wraps Up 2023 With Multi-Million Dollar Private Placement Deal
Latin American licensed producer of medicinal cannabis and cannabis-derived products Blueberries Medical Corp. (CSE:BBM) (OTC:BBRRF) (FRA: 1OA) wrapped up 2023 with an announcement of a non-brokered private placement consisting of the sale of 180,716,00 common shares at CA$0.011 ($0.0083) per common share for aggregate gross proceeds of approximately CA$1,987,876.
拉丁美洲持牌藥用大麻和大麻衍生產品生產商藍莓醫療公司（CSE: BBM）（場外交易代碼：BBRRF）（FRA：1OA）在2023年結束時宣佈進行非經紀私募配售，包括以每股普通股0.011加元（0.0083美元）出售180,716,00股普通股，總收益約爲1,987,876加元。
The net proceeds from the sale of the common shares will be used to repay existing debt and for general corporate and working capital purposes.
出售普通股的淨收益將用於償還現有債務以及一般公司和營運資金用途。
The offering was led by Terraflos Inc., a company with operations throughout Latin America founded and controlled by Facundo Garreton, who serves as chairman, CEO and director of Blueberries.
此次發行由Terraflos Inc. 牽頭，該公司在拉丁美洲開展業務，由藍莓董事長、首席執行官兼董事法昆多·加雷頓創立和控制。
Terraflos is exploring various prospects in Argentina, Mexico and Brazil with plans to expand operations into those markets in the short term.
Terraflos正在阿根廷、墨西哥和巴西探索各種前景，並計劃在短期內將業務擴展到這些市場。
See also: Exclusive: LatAm Cannabis Co. Terraflos, Founded By Former Congressman, Closes $8M Seed Funding Round
另見：獨家：LatAm Cannabis Co.由前國會議員創立的Terraflos完成了800萬美元的種子輪融資
The company's objective is to satisfy food and medicine needs using non-conventional methods, without exploiting natural resources as is common in current methodologies.
該公司的目標是使用非常規方法滿足食品和藥品需求，而不像當前方法那樣開採自然資源。
Earlier this year, Blueberries signed a joint venture agreement with Allied Corp. (OTCQB:ALID). The collaboration includes the production of psychoactive and non-psychoactive derivatives.
今年早些時候，藍莓與聯合公司（OTCQB: ALID）簽署了合資協議。該合作包括生產精神活性和非精神活性衍生物。
By combining Allied's expertise in producing quality cannabis flowers with Blueberries' extraction facilities, the companies have joined forces in sales efforts, while optimizing production capabilities.
通過將Allied在生產優質大麻花方面的專業知識與藍莓的提取設施相結合，兩家公司聯手開展了銷售工作，同時優化了生產能力。
Related News
相關新聞
- Blueberries Medical Q2 Revenue Grows 169%, What About Net Loss?
- Blueberries Provides Corporate Update, Extends Maturity Date Of Convertible Debentures
- Blueberries Medical Reports Q1 2022 Financial Results, Eyes On Argentina's New Medicinal Market
- Blueberries Medical Reports 110% Revenue Growth In 2021
- 藍莓醫療第二季度收入增長169％，淨虧損呢？
- 藍莓提供公司最新情況，延長可轉換債券的到期日
- 藍莓醫學報告2022年第一季度財務業績，着眼於阿根廷的新藥市場
- 藍莓醫療報告稱，2021年收入增長110％
BBRRF Price Action
BBRRF 價格走勢
Blueberries Medical's shares traded 12.7451% higher at $0.0138 per share after the market closed on Friday.
週五收盤後，藍莓醫療的股價上漲了12.7451％，至每股0.0138美元。
Missed the first wave of cannabis investments? Don't make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
錯過了第一波大麻投資浪潮？別再犯那個錯誤了。
專家認爲，大麻庫存已經找到了底線，現在有望實現前所未有的增長。
加入 Benzinga PotProfits。我們的內部大麻股票專家邁克爾·伯傑（Michael Berger）的使命是發現即使在低迷的市場中也有望增長的最有前途的大麻股票。他不遺餘力地爲你帶來最有潛力的兩位數機會！
就在今年，PotProfits投資組合的漲幅火爆，例如：
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF
- 47.10% 使用 $GTBIF
- 使用 $TCNNF 獲得 40.23%
- 21.50% 使用 $VFF
But here's the kicker: Michael is about to release his next potential winners, and he's chomping at the bit to share these ticker symbols with you ASAP.
但關鍵在於：邁克爾即將發佈他的下一個潛在贏家，他正在努力盡快與你分享這些股票代碼。
Don't miss out on the green rush!
千萬不要錯過綠色熱潮！
譯文內容由第三人軟體翻譯。